Contact
searchSearch
HMP Global

Biosimilars Topic Center

Featured Article

Conference Coverage
Real-World Strategies for Implementing Biosimilars
04/12/2023
Hannah Musick
Speakers at AMCP 2023 discussed the current landscape of biosimilars from a payer perspective as well as lessons learned from health system biosimilar adoption. 
Speakers at AMCP 2023 discussed the current landscape of biosimilars from a payer perspective as well as lessons learned from health system biosimilar adoption. 
Speakers at AMCP 2023 discussed...
04/12/2023
First Report Managed Care
From First Report Managed Care
Conference Insider
Addressing and Understanding Challenges Linked With Adopting Biosimilars Into Practice
12/08/2020
In a session at ASHP Midyear 2020, Osama Abdelghany, PharmD, MHA, BCOP Yale New Haven Hospital, and David L Crosby, PharmD, BCOP, BCPS, Dartmouth-Hitchcock Health, provide a variety of clinical, operational, and payer coverage considerations...
In a session at ASHP Midyear 2020, Osama Abdelghany, PharmD, MHA, BCOP Yale New Haven Hospital, and David L Crosby, PharmD, BCOP, BCPS, Dartmouth-Hitchcock Health, provide a variety of clinical, operational, and payer coverage considerations...
In a session at ASHP Midyear...
12/08/2020
Pharmacy Learning Network
Quiz
Identifying Pharmacist Knowledge of a Medication Drug Type
11/24/2020
Based on recent data, pharmacists are more well-informed about which medication type—with more than 80% demonstrating solid knowledge of their safety, efficacy, compatibility, and costs?
Based on recent data, pharmacists are more well-informed about which medication type—with more than 80% demonstrating solid knowledge of their safety, efficacy, compatibility, and costs?
Based on recent data,...
11/24/2020
Pharmacy Learning Network
News
Most Pharmacists Show Good Grasp of Biosimilar Medications, Study Finds
11/20/2020
“Pharmacists, being the drug experts, need to be well aware of the applied handling of biosimilar medicines,” researchers wrote. “They are an integral educator, trailblazer, and advocate of biosimilar integration across all clinical settings.”
“Pharmacists, being the drug experts, need to be well aware of the applied handling of biosimilar medicines,” researchers wrote. “They are an integral educator, trailblazer, and advocate of biosimilar integration across all clinical settings.”
“Pharmacists, being the drug...
11/20/2020
Pharmacy Learning Network
Newsfeed
Biosimilar Infliximab Appears Effective in Crohn`s Disease
12/11/2018
An infliximab biosimilar appears to be safe and effective in infliximab-naive patients with Crohn's disease, according to a recent study.
An infliximab biosimilar appears to be safe and effective in infliximab-naive patients with Crohn's disease, according to a recent study.
An infliximab biosimilar appears...
12/11/2018
Pharmacy Learning Network
News
Etanercept Biosimilar is Effective, Well-Tolerated for Rheumatoid Arthritis
02/16/2018
A recent study examined the efficacy of a biosimilar for treating patients with rheumatoid arthritis who respond inadequately to methotrexate
A recent study examined the efficacy of a biosimilar for treating patients with rheumatoid arthritis who respond inadequately to methotrexate
A recent study examined the...
02/16/2018
Pharmacy Learning Network
News
Biosimilar Infliximab Appears Safe, Effective in IBD Patients
12/15/2017
Researchers examined the effectiveness of switching to a biosimilar version of a drug in patients with IBD. 
Researchers examined the effectiveness of switching to a biosimilar version of a drug in patients with IBD. 
Researchers examined the...
12/15/2017
Pharmacy Learning Network
News
Pharmacist Role in Promoting Proper Biosimilar Usage
12/14/2017
Evelyn Hermes-Desantis, PharmD, BCPS, recently discussed the many factors involved in managing biosimilars in the hospital setting and the role pharmacists play in promoting their appropriate use in the context of safe patient care.
Evelyn Hermes-Desantis, PharmD, BCPS, recently discussed the many factors involved in managing biosimilars in the hospital setting and the role pharmacists play in promoting their appropriate use in the context of safe patient care.
Evelyn Hermes-Desantis, PharmD,...
12/14/2017
Pharmacy Learning Network
News
FDA Approves Another Biosimilar for RA Drug
12/14/2017
The FDA has approved a biosimilar for multiple autoimmune diseases. 
The FDA has approved a biosimilar for multiple autoimmune diseases. 
The FDA has approved a...
12/14/2017
Pharmacy Learning Network
News
FDA Approves First Biosimilar for Breast, Stomach Cancer
12/01/2017
The FDA has approved a biosimilar for two types of cancer.
The FDA has approved a biosimilar for two types of cancer.
The FDA has approved a...
12/01/2017
Pharmacy Learning Network
News
The Challenges of Bringing Biosimilars to Market
11/21/2017
Edward Li, Pharm D, MPH, BCOP, a professor in the Department of Pharmacy Practice at the University of New England College of Pharmacy, explains how industry experts can help bring biosimilars to the market faster.
Edward Li, Pharm D, MPH, BCOP, a professor in the Department of Pharmacy Practice at the University of New England College of Pharmacy, explains how industry experts can help bring biosimilars to the market faster.
Edward Li, Pharm D, MPH, BCOP, a...
11/21/2017
Pharmacy Learning Network

Newsfeed

News
Communication Needed to Improve Biosimilar Transition, Adherence
10/19/2017
Patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis who switched from an originator treatment to a biosimilar stopped taking the biosimilar medication within 6 months, a study showed. 
Patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis who switched from an originator treatment to a biosimilar stopped taking the biosimilar medication within 6 months, a study showed. 
Patients with rheumatoid...
10/19/2017
Pharmacy Learning Network
News
FDA Approves Amgen`s Cheaper Copy of Arthritis Drug Humira
09/23/2016
The FDA has approved a cheaper, biosimilar version of AbbVie's top-selling arthritis drug, Humira.
The FDA has approved a cheaper, biosimilar version of AbbVie's top-selling arthritis drug, Humira.
The FDA has approved a cheaper,...
09/23/2016
Pharmacy Learning Network
News
Novartis Biosimilar Takes Aim at Amgen`s Enbrel
10/23/2015
The FDA has accepted Novartis unit Sandoz's regulatory submission for approval of a biosimilar copy of Amgen's blockbuster anti-TNF drug Enbrel, the Swiss drugmaker said.
The FDA has accepted Novartis unit Sandoz's regulatory submission for approval of a biosimilar copy of Amgen's blockbuster anti-TNF drug Enbrel, the Swiss drugmaker said.
The FDA has accepted Novartis...
10/23/2015
Pharmacy Learning Network
News
FDA Proposes Adding Suffixes to Distinguish Biosimilar Drug Names
08/28/2015
The FDA proposed on Thursday identifying cheaper versions of biologic drugs with a suffix to distinguish them from their more expensive, branded counterparts.
The FDA proposed on Thursday identifying cheaper versions of biologic drugs with a suffix to distinguish them from their more expensive, branded counterparts.
The FDA proposed on Thursday...
08/28/2015
Pharmacy Learning Network
News
Testosterone Cypionate Injection Recalled Due to Crystallization Concerns
04/23/2025
Juliet Gallagher
Eugia US LLC has voluntarily recalled 36,816 vials of Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, distributed in 1 mL single-dose vials (NDC 55150-277-01).
Eugia US LLC has voluntarily recalled 36,816 vials of Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, distributed in 1 mL single-dose vials (NDC 55150-277-01).
Eugia US LLC has voluntarily...
04/23/2025
Pharmacy Learning Network
News
Class II Recall Issued for Unisom Sleep Aid Due to Nitrosamine Impurities
04/23/2025
Juliet Gallagher
Chattem Inc. has voluntarily initiated a Class II recall of its Unisom SleepMinis (Diphenhydramine HCl) 25 mg mini-capsules, distributed in 60-count bottles nationwide.
Chattem Inc. has voluntarily initiated a Class II recall of its Unisom SleepMinis (Diphenhydramine HCl) 25 mg mini-capsules, distributed in 60-count bottles nationwide.
Chattem Inc. has voluntarily...
04/23/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall for Levetiracetam Injection Due to Labeling Discrepancy
04/23/2025
Juliet Gallagher
Dr Reddy’s Laboratories Inc. has initiated a Class I recall of levetiracetam 0.75% in sodium chloride injection following the discovery of a labeling discrepancy that could pose serious health risks.
Dr Reddy’s Laboratories Inc. has initiated a Class I recall of levetiracetam 0.75% in sodium chloride injection following the discovery of a labeling discrepancy that could pose serious health risks.
Dr Reddy’s Laboratories Inc. has...
04/23/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall for Sodium Chloride Irrigation Solution Due to Particulate Contamination
04/17/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for Sodium Chloride Irrigation Solution due to the presence of particulate matter, posing a potential risk during surgical and wound care procedures.
The US Food and Drug Administration (FDA) has issued a Class II recall for Sodium Chloride Irrigation Solution due to the presence of particulate matter, posing a potential risk during surgical and wound care procedures.
The US Food and Drug...
04/17/2025
Pharmacy Learning Network
News
Gabapentin Capsules Recalled Due to Cross-Contamination Concerns
04/17/2025
Hannah Musick
Select lots of nationally distributed Gabapentin Capsules are being recalled due to cross contamination concerns.
Select lots of nationally distributed Gabapentin Capsules are being recalled due to cross contamination concerns.
Select lots of nationally...
04/17/2025
Pharmacy Learning Network
News
FDA Issues Class II Recalls for Multiple Injectable Products Due to Sterility Concerns
04/17/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued Class II recalls for multiple injectable products, including Haloperidol Decanoate and Methocarbamol, due to potential sterility issues linked to bacterial contamination during...
The US Food and Drug Administration (FDA) has issued Class II recalls for multiple injectable products, including Haloperidol Decanoate and Methocarbamol, due to potential sterility issues linked to bacterial contamination during...
The US Food and Drug...
04/17/2025
Pharmacy Learning Network
News
FDA Class III Recall: Tolterodine Tartrate ER Capsules by Major Pharmaceuticals
04/10/2025
Danielle Sposato
A nationwide recall has been initiated for Tolterodine Tartrate Extended-Release Capsules, 2 mg, packaged in 30-count unit dose cartons (NDC 0904-6592-04), and distributed by Major Pharmaceuticals of Indianapolis, IN.
A nationwide recall has been initiated for Tolterodine Tartrate Extended-Release Capsules, 2 mg, packaged in 30-count unit dose cartons (NDC 0904-6592-04), and distributed by Major Pharmaceuticals of Indianapolis, IN.
A nationwide recall has been...
04/10/2025
Pharmacy Learning Network
News
Imprimis NJOF Voluntarily Recalls Ophthalmic Solution Due to Subpotency
04/10/2025
Danielle Sposato
Imprimis NJOF, LLC has issued a voluntary recall of its Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution (1% / 0.5% / 2.5% / 0.5%) after stability testing revealed subpotent results.
Imprimis NJOF, LLC has issued a voluntary recall of its Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution (1% / 0.5% / 2.5% / 0.5%) after stability testing revealed subpotent results.
Imprimis NJOF, LLC has issued a...
04/10/2025
Pharmacy Learning Network
News
Class II Recall Issued for Chlorpromazine Tablets Due to Nitrosamine Impurity
04/10/2025
Danielle Sposato
Glenmark Pharmaceuticals Inc., USA has initiated a voluntary Class II recall of its chlorproMAZINE Hydrochloride Tablets, USP 100 mg, due to current Good Manufacturing Practice (CGMP) deviations
Glenmark Pharmaceuticals Inc., USA has initiated a voluntary Class II recall of its chlorproMAZINE Hydrochloride Tablets, USP 100 mg, due to current Good Manufacturing Practice (CGMP) deviations
Glenmark Pharmaceuticals Inc.,...
04/10/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall for QuVa Pharma Compounded Epidural Drug Products Due to Sterility Concerns
04/03/2025
Juliet Gallagher
QuVa Pharma, Inc. has voluntarily initiated a nationwide Class II recall of multiple compounded epidural drug formulations containing fentanyl citrate combined with bupivacaine or ropivacaine.
QuVa Pharma, Inc. has voluntarily initiated a nationwide Class II recall of multiple compounded epidural drug formulations containing fentanyl citrate combined with bupivacaine or ropivacaine.
QuVa Pharma, Inc. has...
04/03/2025
Pharmacy Learning Network

Interactive Features

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
David T. Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Paul Schulz, MD
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
Ronald Vender, MD, FRCPC
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
Abigail Cline, MD, PhD
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; Ryan Nix, BS, NRP, NCI
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
Videos
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
05/13/2020
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of...
05/13/2020
Pharmacy Learning Network
Videos
Diabetes - Guideline Changes, Adherence, and Newer Drug Issues
09/15/2015
09/15/2015
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use